Pierre Broqua
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
-
- Liver Disease Diagnosis and Treatment 8
- Co-authors
- Jean‐Louis Junien (13 shared papers)Jean‐Michel Luccarini (6 shared papers)Guillaume Wettstein (5 shared papers)Sonia Pezet (2 shared papers)Thomas Guilbert (2 shared papers)Jérôme Avouac (2 shared papers)Yannick Allanore (2 shared papers)Irena Konstantinova (7 shared papers)
- Journals
- Journal of Hepatology (5 papers)Annals of the Rheumatic Diseases (2 papers)Cancer Research (2 papers)Nature Communications (1 paper)Arthritis Research & Therapy (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Pierre Broqua
25 papers receiving 636 citations
Pierre Broqua's Hit Papers
Peers
Comparison fields: 5 of 57
- Hepatology 155
- Epidemiology 331
- Endocrinology, Diabetes and Metabolism 115
- Pathology and Forensic Medicine 83
- Cell Biology 54
Countries citing papers authored by Pierre Broqua
This map shows the geographic impact of Pierre Broqua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Broqua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Broqua more than expected).
Fields of papers citing papers by Pierre Broqua
This network shows the impact of papers produced by Pierre Broqua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Broqua. The network helps show where Pierre Broqua may publish in the future.
Co-authors
The 25 scholars most cited alongside Pierre Broqua, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 128 | |
| 2 | 2017 | 118 | |
| 3 | 2016 | 82 | |
| 4 | 2017 | 68 | |
| 5 | 2020 | 58 | |
| 6 | 2001 | 41 | |
| 7 | Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD Hit paper breakdown → | 2025 | 41 |
| 8 | 2024 | 37 | |
| 9 | 2021 | 18 | |
| 10 | 2020 | 16 | |
| 11 | 1998 | 12 | |
| 12 | 2016 | 3 | |
| 13 | 2016 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2025 | 2 | |
| 16 | 2015 | 2 | |
| 17 | 2015 | 2 | |
| 18 | 2018 | 2 | |
| 19 | 2014 | 2 | |
| 20 | 2020 | 1 |
About Pierre Broqua
Pierre Broqua is a scholar working on Molecular Biology, Epidemiology, Cell Biology, Pulmonary and Respiratory Medicine and Physiology, having authored 25 papers that have together received 643 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Hippo pathway signaling and YAP/TAZ (5 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Diet, Metabolism, and Disease (3 papers), Cancer-related Molecular Pathways (2 papers), Carbohydrate Chemistry and Synthesis (2 papers), Pancreatitis Pathology and Treatment (2 papers) and Lysosomal Storage Disorders Research (2 papers). The work is most often cited by research in Hepatology (155 citations), Epidemiology (331 citations), Endocrinology, Diabetes and Metabolism (115 citations), Pathology and Forensic Medicine (83 citations) and Cell Biology (54 citations). Pierre Broqua has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jean‐Louis Junien, Jean‐Michel Luccarini, Guillaume Wettstein, Sonia Pezet, Thomas Guilbert, Jérôme Avouac, Yannick Allanore, Irena Konstantinova, Anabel Fernández‐Iglesias and Jaime Bosch. Their work appears in journals such as Journal of Hepatology, Annals of the Rheumatic Diseases, Cancer Research, Nature Communications and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.